Search - tctmd.com

Displaying 21 - 40 of 124

Sort: Relevancy | Date

Acute HF Patients Live Longer When Seen by Specialists

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

News Daily News

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

Yael L. Maxwell

August 08, 2024

ACC/AHA Update Performance, Quality Measures for HF Care

News Daily News

ACC/AHA Update Performance, Quality Measures for HF Care

August 08, 2024

Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF

News Daily News

Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF

July 19, 2024

Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement

Presentation NY Valves 2024

Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement

Presenter: Daijiro Tomii

June 05, 2024

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

News Daily News

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

May 24, 2024

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

News Conference News ESC Heart Failure 2024

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

Michael O'Riordan

May 13, 2024

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

News Conference News ACC 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

April 11, 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

April 06, 2024

Antihypertensives Linked to Lower Long-term Dementia Risk

News Daily News

Antihypertensives Linked to Lower Long-term Dementia Risk

April 01, 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

News Daily News

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

December 29, 2023

RNA-Interference Agent Zilebesiran Looks Promising for BP-Lowering KARDIA-1

News Conference News AHA 2023

RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1

November 11, 2023

TCT 54: Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement

Presentation TCT 2023

TCT 54: Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Daijiro Tomii

October 26, 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

October 18, 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

October 11, 2023

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

News Daily News

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Michael O'Riordan

September 27, 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

September 01, 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.